| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3207207 | Journal of the American Academy of Dermatology | 2011 | 22 Pages |
Abstract
Extemporaneous compounding helps physicians to individualize treatment to the patient's specific needs and to create topical preparations that are not otherwise commercially available. However, comparative effectiveness studies are needed to determine whether or not topical use of systemic therapeutics is more beneficial than existing therapies.
Keywords
MTXgranulocyte-macrophageRDBPCTISDNBTX-AAMPPHNExtemporaneousGTNAHNAGAPGE2APCadenosine monophosphateandrogenetic alopeciaIsosorbide dinitrateComprehensive reviewTranexamic acidCompoundingBotulinum toxin type AColony-stimulating factorCSFMethotrexateTopicalPercutaneous penetrationpostherpetic neuralgiaActivated protein CProstaglandin E2Glyceryl trinitrate
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Hsien-Yi MD, Tsen-Fang MD,